{
    "prompt": "\n    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n    {\n        \"Status\": \"no_match\",\n        \"Message\": \"No drugs are FDA-approved for the provided context\"\n    }\n    \n    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n    {\n        \"Status\": \"success\",\n        \"Treatment 1\": {\n            \"Disease Name\": ,\n            \"Disease Phase or Condition\": ,\n            \"Drug Name\": ,\n            \"Prior Treatment or Resistance Status\": ,\n            \"Genomic Features\": \n            \"FDA-approval status\":\n            \"Link to FDA-approved Label\":\n            }\n    }\n    Query: \n    The following is a summarized molecular profile from MSK-IMPACT.\n    Based on this profile, answer with the appropriate treatments for this patient in the format above.\n    Patient ID: P-0010742\nAge: 51\nGender: Female\nSample ID: P-0010742-T01-IM5\nGene Panel: IMPACT410\nCancer Type: Colon Adenocarcinoma\nSample Type: Metastasis\nTumor Purity: 30.0%\n=============\nDNA Variants:\nAPC c.3927_3931del (p.E1309Dfs*4) - in 20.00% of 366 reads\nNRAS c.35G>A (p.G12D) - in 59.00% of 1328 reads\nPTPRD c.1311G>C (p.Q437H) - in 11.00% of 1097 reads\nRARA c.118G>A (p.A40T) - in 58.00% of 1182 reads\nTP53 c.626_627delGA (p.R209Kfs*6) - in 55.00% of 1040 reads\nCNA Data:\nFLT3 - High Level Amplification\nFLT1 - High Level Amplification\nCDK8 - High Level Amplification\nStructural Variants:\nPRMT8 - APC (TRANSLOCATION)\n    ",
    "response": "{\n  \"Status\": \"no_match\",\n  \"Message\": \"No drugs are FDA-approved for the provided context\"\n}"
}